Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88318383 | FILING DATE | 02/27/2019 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | CIURPITA, DREW PETER F |
L.O. ASSIGNED | 114 |
PUB INFORMATION |
|||
RUN DATE | 12/07/2019 | ||
PUB DATE | N/A | ||
STATUS | 680-APPROVED FOR PUBLICATION | ||
STATUS DATE | 12/06/2019 | ||
LITERAL MARK ELEMENT | RANDOX DISCOVERY | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | YES | 44D | NO | 44D | NO |
44E | NO | 44E | YES | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | RANDOX DISCOVERY |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Randox Laboratories Ltd |
ADDRESS | Ardmore Diamond Road Crumlin, Antrim, BT294QY |
ENTITY | 99-limited company (ltd.) |
CITIZENSHIP | GB5 |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 001 |
DESCRIPTION TEXT | Diagnostic preparations for scientific purposes; chemical reagents for scientific or medical research and for use in the analysis of food products; enzymes for use in scientific and medical research applications; protein arrays for use in scientific and medical research applications; diagnostic preparations for analysis of food products and water for scientific or research use; clinical diagnostic preparations for clinical or medical laboratory use; clinical diagnostic reagents for in vitro use for clinical or medical laboratory use; chemical reagents other than for medical or veterinary purposes, namely, chemical reagents for detection and monitoring of disease states in vitro for laboratory research purposes; diagnostic proteins, namely, protein arrays for scientific and medical research featuring antibodies and antigens used for monitoring of disease states in vitro |
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Diagnostic preparations and substances for medical and veterinary purposes; diagnostic kits in the nature of clinical chemistry and immunology test kits for medical use in the detection and monitoring of disease states in vitro, namely, chemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiac, DOA, stroke, metabolic, cancer, diabetes, fertility, thyroid and DNA arrays; clinical diagnostic preparations, for medical or veterinary use; clinical diagnostic reagents for in vivo use for medical or veterinary purposes; diagnostic scanning agents for in vivo use for medical or veterinary purposes; diagnostic testing materials for medical use in the detection and monitoring of disease states in vitro, namely, chemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiac, DOA, stroke, metabolic, cancer, diabetes, fertility, thyroid and DNA arrays; medical diagnostic proteins, namely, protein arrays for medical diagnostic purposes featuring antibodies and antigens used for medical detection of disease states in vitro; chemical reagents, namely, chemical reagents for detection and monitoring of disease states in vitro |
INTERNATIONAL CLASS | 009 |
DESCRIPTION TEXT | Downloadable computer software for use in conjunction with in vitro diagnostic testing apparatus, namely, software for controlling medical and clinical sample processing, sample result reporting and test apparatus system robotics; computer hardware for or relating to the analysis, monitoring, research and/or reporting of clinical data; downloadable computer programs for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systems, namely, computer hardware and downloadable software for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systems for use in conjunction with in vitro diagnostic testing apparatus, namely, downloadable computer software and hardware for controlling medical and clinical sample processing; downloadable computer databases and computer databases recorded on computer media for use in connection with in vitro diagnostic testing apparatus, namely, downloadable electronic data files featuring medical diagnostic sample results; scientific and optical apparatus and instruments, namely, a benchtop analytical system composed of barcode scanner and associated software for reading barcodes, a chemiluminescent detection system in the nature of instruments for measuring chemiluminescence, a temperature controlled incubator for laboratory use, and an electronic reagent and patient sample dispenser, suitable for protein and DNA arrays for or relating to the analysis, monitoring, research and/or reporting of clinical data, for use in vitro diagnostic testing procedures for clinical, veterinary, food and toxicological analysis; clinical analyzers not for medical and veterinary use, namely, acidity analyzers, liquid analyzers, residual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs for laboratory use; light detectors for use in vitro diagnostic testing procedures, namely, a chemiluminescence detection system not for medical purposes; parts and fittings for all the aforesaid goods, namely, replacement parts and fittings |
INTERNATIONAL CLASS | 010 |
DESCRIPTION TEXT | Medical apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins and hormones; diagnostic apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; diagnostic imaging apparatus for medical use, namely, electromechanical diagnostic analyser utilizing a chemiluminescent detection system for use in in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; medical diagnostic testing apparatus and instruments for use in immunoassay procedures, namely, for use in the measurement of antibodies, immunoglobulins, hormones and drugs representing various drug classes; light detectors for use in vitro diagnostic testing procedures, namely, a chemiluminescence detection system for medical purposes; clinical analyzers for medical and veterinary use, namely, acidity analyzers, liquid analyzers, residual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 009 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
PRIORITY CLAIMED | SEC. 44(D) ON United Kingdom |
APPLICATION NO. | 3379045 |
APPLICATION FILING DATE | 02/27/2019 |
FOREIGN REG NO. | UK0000337904 |
FOREIGN REG DATE | 07/19/2019 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 02/27/2029 |
FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
12/06/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 017 |
12/05/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 016 |
12/05/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 015 |
12/05/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 014 |
12/05/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 013 |
10/22/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 012 |
10/22/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 011 |
10/15/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 010 |
05/15/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 009 |
05/15/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 008 |
05/15/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 007 |
05/08/2019 | DOCK | D | ASSIGNED TO EXAMINER | 006 |
03/19/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 005 |
03/11/2019 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 004 |
03/11/2019 | ALIE | A | ASSIGNED TO LIE | 003 |
03/06/2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 002 |
03/02/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Daniel Frohling |
CORRESPONDENCE ADDRESS | Daniel Frohling LOEB & LOEB LLP 321 North Clark Street Suite 2300 Chicago, IL 60654 |
DOMESTIC REPRESENTATIVE | NONE |